C&C International Co., Ltd. (KOSDAQ:352480)
21,550
+100 (0.47%)
At close: Sep 3, 2026
C&C International Revenue
C&C International had revenue of 73.32B KRW in the quarter ending June 30, 2026, a decrease of -0.78%. This brings the company's revenue in the last twelve months to 292.76B, up 8.32% year-over-year. In the year 2025, C&C International had annual revenue of 288.48B with 1.98% growth.
Revenue (ttm)
292.76B
Revenue Growth
+8.32%
P/S Ratio
1.00
Revenue / Employee
485.50M
Employees
603
Market Cap
291.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 288.48B | 5.59B | 1.98% |
| Dec 31, 2024 | 282.88B | 62.56B | 28.39% |
| Dec 31, 2023 | 220.33B | 89.72B | 68.70% |
| Dec 31, 2022 | 130.61B | 39.31B | 43.06% |
| Dec 31, 2021 | 91.29B | 1.68B | 1.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cosmecca Korea | 772.05B |
| CLIO Cosmetics Co.,Ltd | 329.59B |
| Englewood Lab | 218.19B |
| Icure Pharmaceutical Incorporation | 114.43B |
| Genic | 114.29B |
| Manyo Factory | 107.18B |
| BBIA Co., Ltd. | 77.16B |
| Bonne | 42.19B |